Updated: 6th July 2026
Reviewed by: David Small BSc (Hons), MSc, MTOPRA (Founder and CEO)
The Next Generation of Connected Medical Devices
The healthcare industry is entering a new era of connected care. Medical devices are no longer isolated pieces of equipment operating independently within hospitals or clinics. Increasingly, they form part of an interconnected digital ecosystem that enables clinicians to access real-time patient information, monitor devices remotely and deliver more responsive care.
At the centre of this transformation is fifth-generation mobile technology, better known as 5G.
Unlike previous generations of mobile networks, 5G has been designed to support mission-critical applications that demand extremely high reliability, ultra-low latency and the ability to connect thousands of devices simultaneously. These capabilities make it particularly well suited to modern healthcare environments, where connected medical devices must exchange information quickly, securely and reliably.
From wearable sensors and smart infusion pumps to AI-powered diagnostic platforms and remote patient monitoring systems, manufacturers are increasingly developing products that depend on continuous network connectivity.
For medical device manufacturers, however, faster connectivity brings new responsibilities.
As medical devices become more connected, regulators expect manufacturers to demonstrate not only that their devices perform safely and effectively, but also that the supporting communications infrastructure, cybersecurity controls and software lifecycle processes have been properly considered throughout the product’s lifecycle.
Understanding how 5G influences medical device design, risk management and regulatory compliance is therefore becoming essential for manufacturers developing the next generation of digital health technologies.
Building Connected Medical Device Software?
Many 5G-enabled and connected medical devices rely on complex software that must be developed and maintained throughout its lifecycle. Learn how IEC 62304 supports compliant medical device software development, including software lifecycle processes, verification, validation, maintenance and configuration management.
What is 5G?
5G is the fifth generation of mobile communications technology, designed to provide significantly higher performance than previous wireless standards.
Compared with 4G networks, 5G offers:
- Significantly faster data transfer speeds
- Ultra-low communication latency
- Increased network reliability
- Greater capacity for connected devices
- Improved energy efficiency
- Enhanced support for Internet of Medical Things (IoMT) devices
While consumers often associate 5G with faster smartphone downloads, its greatest impact may be within healthcare, manufacturing and industrial automation, where connected systems rely on the rapid exchange of critical information.
For medical devices, the ability to transmit large volumes of clinical data almost instantaneously creates opportunities that were previously impractical using conventional wireless technologies.
Want to Learn More About the Internet of Medical Things?
5G connectivity is helping to power the next generation of connected healthcare, but it is only one part of the wider Internet of Medical Things (IoMT) ecosystem. Discover how connected medical devices, wearable technologies and remote patient monitoring are transforming healthcare in our Complete Guide to the Internet of Medical Things (IoMT).
Why 5G Matters for Medical Devices
Traditional medical devices were typically designed to operate as standalone systems.
Today’s devices are very different.
Many modern products continuously exchange information with:
- Electronic Health Record (EHR) systems
- Hospital information systems
- Cloud platforms
- Artificial intelligence services
- Clinical decision support software
- Mobile applications
- Healthcare professionals
- Other connected medical devices
This connected approach enables healthcare providers to make faster clinical decisions while improving patient monitoring and operational efficiency.
5G provides the communications infrastructure needed to support these increasingly complex healthcare ecosystems.
The Rise of Connected Medical Devices
Connected medical devices are often referred to as part of the Internet of Medical Things (IoMT).
The IoMT describes networks of medical devices, software platforms and healthcare systems that communicate electronically to collect, exchange and analyse clinical information.
Examples include:
- Continuous glucose monitoring systems
- Wearable ECG monitors
- Smart inhalers
- Connected insulin pumps
- Remote cardiac monitoring devices
- Portable ultrasound systems
- Smart infusion pumps
- Digital blood pressure monitors
- Home dialysis systems
- Connected imaging equipment
Rather than storing information locally, these devices can securely transmit patient data to clinicians in near real time, enabling faster diagnosis, earlier intervention and more personalised treatment.
As healthcare continues to shift towards remote care and community-based services, reliable connectivity is becoming just as important as the medical device itself.
Key Benefits of 5G Connectivity in Healthcare
Real-Time Remote Patient Monitoring
Remote patient monitoring has become one of the fastest-growing areas of digital healthcare.
Patients with chronic conditions can now wear connected devices that continuously monitor vital signs such as:
- Heart rate
- Blood glucose
- Blood pressure
- Oxygen saturation
- Respiratory rate
- Cardiac rhythm
Using 5G connectivity, this information can be transmitted securely to healthcare professionals in near real time.
This allows clinicians to identify deteriorating patients earlier, intervene more quickly and reduce unnecessary hospital admissions.
For patients living in rural or underserved areas, remote monitoring also improves access to specialist care without requiring frequent hospital visits.
Faster Clinical Decision-Making
Healthcare professionals increasingly rely on real-time clinical information.
5G enables large volumes of patient data to be transferred rapidly between medical devices, hospital systems and cloud platforms, supporting:
- Faster diagnostic reporting
- Improved multidisciplinary collaboration
- Real-time imaging review
- More responsive emergency care
- Better coordination between healthcare providers
For time-critical clinical situations, reducing communication delays can have a direct impact on patient outcomes.
Supporting the Future of Digital Healthcare
As digital health technologies continue to evolve, manufacturers are designing increasingly sophisticated connected medical devices that rely on continuous communication rather than standalone operation.
The combination of 5G, cloud computing, edge processing and artificial intelligence is enabling healthcare systems that are more responsive, more data-driven and better connected than ever before.
However, greater connectivity also introduces additional considerations around reliability, cybersecurity, interoperability and regulatory compliance—topics that manufacturers must address throughout the product lifecycle.
How Patient Guard Can Help
Navigating the regulatory landscape for 5G-enabled medical devices can be complex. At Patient Guard, we specialize in helping manufacturers ensure compliance with EU MDR, FDA, and cybersecurity regulations. Our team provides expert guidance on technical documentation, risk assessment, and regulatory approvals, ensuring your device meets the highest safety standards.
Frequently Asked Questions About Medical Device Connectivity and 5G
A 5G medical device is a medical device that uses fifth-generation mobile network technology to securely transmit, receive or exchange healthcare data. Examples include remote patient monitoring devices, wearable sensors, connected infusion pumps and portable diagnostic systems.
5G enables faster data transmission, lower latency and more reliable connectivity than previous mobile networks. This allows connected medical devices to support real-time patient monitoring, faster clinical decision-making and improved communication between healthcare systems.
The Internet of Medical Things (IoMT) refers to a network of connected medical devices, software and healthcare systems that collect, share and analyse clinical data. 5G technology helps support IoMT by providing reliable, high-speed connectivity for large numbers of devices.
5G-enabled medical devices must comply with EU MDR and FDA regulations, ensuring safety, performance validation, and data security. Compliance with interoperability standards such as HL7 and DICOM is also required for seamless healthcare integration.
Yes. Medical devices that use 5G connectivity must still comply with the requirements of the EU Medical Device Regulation (EU MDR 2017/745) or the In Vitro Diagnostic Regulation (IVDR 2017/746), depending on the intended purpose of the device. Connectivity does not change the regulatory framework but may introduce additional design, cybersecurity and risk management considerations.
Not necessarily. Device classification is based on the intended purpose and the applicable classification rules under the MDR or IVDR. However, if 5G connectivity enables additional software functionality or influences clinical decision-making, the classification may need to be reassessed.
Connected medical devices can face additional risks, including network interruptions, cybersecurity threats, data integrity issues and interoperability challenges. Manufacturers should identify and manage these risks through appropriate risk management, software development and post-market surveillance processes.
Yes. One of the biggest advantages of 5G is its ability to support continuous remote patient monitoring. Connected devices can securely transmit patient data in near real time, enabling healthcare professionals to monitor patients remotely and respond more quickly to changes in their condition.
Yes. Many connected medical devices incorporate artificial intelligence (AI) to analyse patient data, support clinical decision-making or automate certain functions. Where AI is used, manufacturers may also need to consider applicable requirements under the EU AI Act alongside MDR or IVDR compliance.
Yes. As medical devices become increasingly connected, cybersecurity becomes a critical part of ensuring patient safety and protecting sensitive healthcare data. Manufacturers should implement appropriate security controls throughout the device lifecycle and monitor emerging cyber threats after the device has been placed on the market.
Patient Guard supports manufacturers developing connected medical devices by providing regulatory and quality consultancy services, including MDR and IVDR compliance, technical documentation, ISO 14971 risk management, IEC 62304 software lifecycle support, cybersecurity guidance, clinical evaluation and regulatory strategy for connected healthcare technologies.
References
This guide is based on the following international standards, legislation and official regulatory guidance relating to connected medical devices, Software as a Medical Device (SaMD), cybersecurity and digital healthcare technologies.
| Organisation | Reference | Why it's relevant |
|---|---|---|
| European Union | Regulation (EU) 2017/745 on Medical Devices (MDR) | Provides the legal framework governing connected medical devices placed on the European market, including software, safety, performance and post-market obligations. |
| European Union | Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices (IVDR) | Establishes the regulatory framework for connected in vitro diagnostic medical devices and associated software. |
| International Electrotechnical Commission (IEC) | IEC 62304 – Medical Device Software – Software Life Cycle Processes | Defines the internationally recognised software lifecycle processes expected for connected medical device software throughout development, maintenance and change management. |
| International Organization for Standardization (ISO) | ISO 14971:2019 – Medical Devices – Application of Risk Management to Medical Devices | Provides the internationally recognised framework for identifying and controlling risks associated with connected medical devices, including communication and cybersecurity risks. |
| U.S. Food and Drug Administration (FDA) | Software as a Medical Device (SaMD) | Explains the FDA's regulatory approach to standalone medical device software and connected digital health technologies. |
| Medicines and Healthcare products Regulatory Agency (MHRA) | Software and Artificial Intelligence (AI) as a Medical Device | Provides UK regulatory guidance on software-enabled and connected medical devices, including AI-enabled healthcare technologies. |
Connected healthcare technologies, software regulation and cybersecurity requirements continue to evolve. Manufacturers should always consult the latest published legislation, recognised standards and official regulatory guidance when developing, validating and maintaining connected medical devices throughout their lifecycle.
Patient Guards Recent Posts
IVDR Performance Evaluation Explained: A Complete Guide for Manufacturers
Performance Evaluation is one of the most important requirements under the EU In Vitro Diagnostic Regulation (IVDR). Every manufacturer must demonstrate that their in vitro diagnostic medical device achieves its intended purpose through robust scientific validity, analytical performance and clinical performance evidence. This guide explains every stage of IVDR Performance Evaluation, including Performance Evaluation Plans (PEPs), Performance Evaluation Reports (PERs), Post-Market Performance Follow-up (PMPF) and how Performance Evaluation supports successful CE marking under Regulation (EU) 2017/746.
IVDR Classification Explained: A Complete Guide to Class A, B, C and D IVDs
Understanding how your in vitro diagnostic device is classified under the EU IVDR is one of the first and most important steps towards regulatory compliance. This guide explains the IVDR classification rules, the differences between Class A, B, C and D IVDs, how Annex VIII is applied, and how classification affects conformity assessment, technical documentation and Notified Body involvement.
When Do You Need New Biocompatibility Testing for a Medical Device?
A material change, supplier switch, manufacturing transfer or design modification does not automatically require new ISO 10993 biocompatibility testing. Learn how manufacturers use Biological Evaluation Plans (BEPs), chemical characterisation, toxicological risk assessments and Biological Evaluation Reports (BERs) to determine whether existing biological evidence remains valid or whether additional testing is required under ISO 10993-1, the EU MDR and FDA expectations.
Patient Guards Related Services
Patient Guards Regulatory Tools
Need Training?
Do you need training on Quality Management Systems or EU MDR/ EU IVDR? then check out our training courses.
